Inhibition of SOD1 trimerization is a novel drug target for ALS disease.

Saved in:
Bibliographic Details
Title: Inhibition of SOD1 trimerization is a novel drug target for ALS disease.
Authors: Woo, Tae-Gyun1 (AUTHOR), Han, Jin1 (AUTHOR), Kim, Yuju1 (AUTHOR), Hwang, Young jun2 (AUTHOR), Lee, Mua2 (AUTHOR), Kang, So-mi2 (AUTHOR), Park, Soyoung2 (AUTHOR), Ji, Yeongseon2 (AUTHOR), Chung, Yeon-Ho1 (AUTHOR), Baek, Songyoung1 (AUTHOR), Shin, Eunbyeol1 (AUTHOR), Minju-Kim1 (AUTHOR), Jang, Hyewon3 (AUTHOR), Shin, Yun-Jeong3 (AUTHOR), Kwon, Yonghoon3 (AUTHOR), Kim, Bae-Hoon1,2 (AUTHOR), Park, Bum-Joon1,2 (AUTHOR) bjpark1219@pusan.ac.kr
Source: Translational Neurodegeneration. 5/12/2025, Vol. 14 Issue 1, p1-18. 18p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Be the first to leave a comment!
You must be logged in first